J. Klijn

The Lancet · 2001–2008

A researcher in the Science corpus: 12 papers; trusts 0 researchers and is trusted by 0 researchers here, as inferred from the citation graph.

Who trusts J. Klijn overall

1. H. Horlings
2. Jelle J. Goeman

Papers from J. Klijn's perspective

Ordered by how strongly the researchers J. Klijn trusts endorse each paper. Same corpus, a different order for every researcher.

1. Genes that mediate breast cancer metastasis to lung (Nature)
2. Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer. (The Lancet)
3. Gene Expression Signature of Fibroblast Serum Response Predicts Human Cancer Progression: Similarities between Tumors and Wounds (PLoS Biology)
4. A global test for groups of genes: testing association with a clinical outcome (Bioinform.)
5. A Simple Sequentially Rejective Multiple Test Procedure
6. A multigenic program mediating breast cancer metastasis to bone. (Cancer Cell)
7. Involvement of chemokine receptors in breast cancer metastasis (Nature)
8. CXCR4: a key receptor in the crosstalk between tumor cells and their microenvironment. (Blood)
9. Gene Ontology Consortium: The Gene Ontology (GO) database and informatics resource (Nucleic Acids Res.)
10. Re: Germline BRCA1 Mutations and a Basal Epithelial Phenotype in Breast Cancer

Their papers

• Subtypes of breast cancer show preferential site of relapse. (2008) — 805 citations
• Low-penetrance susceptibility to breast cancer due to CHEK2*1100delC in noncarriers of BRCA1 or BRCA2 mutations (2002) — 980 citations
• Long-term risk of cardiovascular disease in 10-year survivors of breast cancer. (2007) — 865 citations
• Definition of clinically distinct molecular subtypes in estrogen receptor-positive breast carcinomas through genomic grade. (2007) — 829 citations
• Strong Time Dependence of the 76-Gene Prognostic Signature for Node-Negative Breast Cancer Patients in the TRANSBIG Multicenter Independent Validation Series (2007) — 1,014 citations
• Prediction of BRCA1 Status in Patients with Breast Cancer Using Estrogen Receptor and Basal Phenotype (2005) — 669 citations
• Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. (2005) — 7,387 citations
• Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer. (2005) — 2,816 citations
• Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition. (2004) — 1,701 citations
• Pooled analysis of prognostic impact of urokinase-type plasminogen activator and its inhibitor PAI-1 in 8377 breast cancer patients. (2002) — 643 citations
• Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trial. (2002) — 2,022 citations
• Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation. (2001) — 962 citations